It has been shown that high expression of PD-L1 in tumor was associated with poor prognosis [6–8] and that PD-L1-positive patients with lung cancer or esophageal cancer had a higher response rate to immunotherapy [9, 10]. The gene discussed is CD274; the disease is neoplasm.